Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 sept. 2010 09h00 HE | Source: Tufts Center for the Study of Drug Development

Approval Success Rates Higher for Smaller Firms Among Top 50 Pharmaceutical Companies, According to Tufts Center for the Study of Drug Development

BOSTON, MA--(Marketwire - September 9, 2010) - The top 10 pharmaceutical companies out of the world's top 50 have lower estimated overall clinical approval success rates than do smaller firms in that...
11 août 2010 09h00 HE | Source: Tufts Center for the Study of Drug Development

Portfolio Management Is Key to Improved Drug Development Productivity, According to Tufts Center for the Study of Drug Development

BOSTON, MA--(Marketwire - August 11, 2010) - Drug developers need to change the way they allocate resources for new product development, lifecycle management, and business development and...
02 août 2010 08h30 HE | Source: Clinical Architecture

UMass Memorial Health Care Selects Interoperability Solution From Clinical Architecture for More Meaningful Information Exchange

CARMEL, IN--(Marketwire - August 2, 2010) - Clinical Architecture today announced that UMass Memorial Health Care, the largest healthcare system in Central and Western Massachusetts, has...
08 juil. 2010 09h00 HE | Source: Tufts Center for the Study of Drug Development

Comparative Effectiveness Research Could Alter Pharmaceutical Care in the United States, According to Tufts Center for the Study of Drug Development

BOSTON, MA--(Marketwire - July 8, 2010) - Comparative effectiveness research, which assesses the relative strengths and weaknesses of various medical interventions, could help close the gap...
05 mai 2010 09h00 HE | Source: Tufts Center for the Study of Drug Development

Rising Clinical Trial Complexity Continues to Vex Drug Developers, According to Tufts Center for the Study of Drug Development

BOSTON, MA--(Marketwire - May 5, 2010) - Growing clinical trial complexity continues to challenge the ability of pharmaceutical and biotechnology companies to contain the ever-rising cost of...
15 avr. 2010 09h00 HE | Source: Jockimo Inc.

ImagenGlass by Jockimo Incorporated Featured on Cover of Glass Magazine

NEWPORT BEACH, Calif., April 15, 2010 (GLOBE NEWSWIRE) -- Jockimo Incorporated – a leading innovator and developer of advanced architectural products and specialty art glass – today...
12 avr. 2010 12h16 HE | Source: IMSI/Design

New TurboCAD Deluxe 17 Available

NOVATO, CA--(Marketwire - April 12, 2010) - IMSI®/Design, the developer of the #1 best-selling CAD in retail, announced today that an upgraded TurboCAD® Deluxe 17 is now available. ...
06 avr. 2010 09h00 HE | Source: Tufts Center for the Study of Drug Development

New Approaches to R&D May Prove Best Path for Drug Developers, According to Tufts Center for the Study of Drug Development

BOSTON, MA--(Marketwire - April 6, 2010) - Innovative approaches to drug development, including alliances and partnerships, may prove the best way to increase the rate at which the...
24 mars 2010 12h16 HE | Source: IMSI/Design

New TurboCAD Pro 17 Gets Speedy Upgrade

NOVATO, CA--(Marketwire - March 24, 2010) - IMSI®/Design, the developer of the #1 best-selling CAD in retail, announced today that it has significantly increased the performance of its...
16 mars 2010 09h00 HE | Source: Jockimo Inc.

Jockimo Incorporated Introduces ImagenGlass

NEWPORT BEACH, Calif., March 16, 2010 (GLOBE NEWSWIRE) -- Jockimo Incorporated – a leading innovator and developer of advanced architectural products and specialty art glass – today...

Page précédente